A promising “two-in-one” experimental drug could tackle both type 2 diabetes and heart disease by slashing cholesterol and ...

Understanding how cells turn genes on and off is one of biology's most enduring mysteries. Now, a new technology developed by ...

Pancreas development in pigs resembles humans much more closely than does the established mouse model. An international team ...

Caribou Biosciences shares rose after its CAR-T therapies showed high response rates and durable remissions in lymphoma and myeloma trials.

A company’s plan to edit the genomes of human embryos worries some researchers — but it might reflect the changing attitudes towards the controversial approach.

A six-month clinical trial found that a supplement combining citrus and grape extracts, hesperidin, and chromium ...

In a first for adults in Singapore, scientists are conducting gene editing trials on heart patients to correct defects at ...

The U.S. government is divesting from mRNA vaccines, but will other uses of the technology be spared? In a time of ...

A researcher at the University of Houston finds management of diabetic ketoacidosis may center around reducing ketone levels ...

Vertex Pharmaceuticals Incorporated remains a leader in CF treatments, fueling robust cash flow and pipeline expansions.

With $80 million in funding from a list of high-profile backers, the startup is developing bifunctional antibodies that drag ...